1. Short title This Act may be cited as the Fostering Innovation in Medical Imaging Act of 2017 . 2. Approval of applications for certain diagnostic medical imaging devices Section 520 of the Federal Food, Drug, and Cosmetic Act ( 42 U.S.C. 360j ) is amended by adding at the end the following: (p) Diagnostic imaging devices intended for use with contrast agents (1) The Secretary may, subject to the succeeding provisions of this subsection, approve an application (or supplement to such an application) submitted under section 515 with respect to an applicable medical imaging device, or, in the case of an applicable medical imaging device for which a notification was submitted under section 510(k) (or a supplement to such a notification), may make a substantial equivalence determination with respect to such applicable medical imaging device, if the indications and conditions of use proposed in such application or notification do not involve the use of a contrast agent— (A) in a concentration, rate of administration, or route of administration that is different from those described in the approved labeling of the contrast agent; (B) in a region, organ, or system of the body that is different from those described in the approved labeling of the contrast agent, unless the Secretary determines, based on information contained in the application or notification involved, that the difference does not reduce the safety of the contrast agent when used with the device; (C) in a new patient population for which the contrast agent is determined by the Secretary to pose an increased risk